Blockchain Registration Transaction Record

Cardio Diagnostics to Showcase AI Heart Risk Tools at Benefits Conferences

Cardio Diagnostics Holdings to exhibit AI-powered cardiovascular risk assessments at four benefits conferences in June, targeting employers and brokers to reduce heart disease costs and improve workforce health.

This news matters because cardiovascular disease is a leading cause of healthcare spending and lost productivity for employers. Cardio Diagnostics' AI-powered assessments could help companies identify at-risk employees earlier, potentially reducing costs and improving health outcomes. For benefits decision-makers, this represents an opportunity to adopt innovative, data-driven strategies for managing one of the most significant health and financial risks in the workplace.